Ledger.Open graph →
SEC Form D · filed August 20, 2020

Janus Biotherapeutics, Inc

Offering
$4.0M
Sold
$668K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WELLESLEY, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Grayson Lipford · Cambridge, MAExec · DirectorChristine De Los Reyes · Acton, MADirectorJonathan Reis · Cambridge, MADirectorJoseph Baron · Cambridge, MAExec · DirectorGrayson Lipford · Wellesley, MAExec · DirectorChristine De Los Reyes · Acton, MADirectorJonathan Reis · Cambridge, MADirectorJoseph Baron · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗